CIK 0000805928
- Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411301878
- Phone
- +1 386-462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 10,000 shares at $6.56 ($65,600)
- 4 Open-market buy Director bought 10,000 shares at $6.11 ($61,100)
- 4 Option exercise Director acquired 6,459 shares (option exercise)
- 4 Option exercise Director acquired 6,459 shares (option exercise)
- 4 Option exercise Director acquired 6,459 shares (option exercise)
- 4 Open-market sale Director sold 41,980 shares at an average $8.71 ($365,780)
- 4 Option exercise Director acquired 6,459 shares (option exercise)
- 4 Option exercise Director acquired 6,459 shares (option exercise)
- 4 Open-market sale Director sold 7,468 shares at an average $9.23 ($68,899)
- 4 Option exercise Director acquired 28,750 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Human Resources Officer gave up 4,270 shares (to pay taxes)
- 4 Shares withheld for taxes VP Operations gave up 2,769 shares (to pay taxes)
- 4 Shares withheld for taxes VP Peripheral Nerve Science gave up 2,769 shares (to pay taxes)
- 4 Option exercise CEO acquired 37,975 shares (option exercise)
- 4 Shares withheld for taxes General Counsel and CCO gave up 2,634 shares (to pay taxes)
- 4 Shares withheld for taxes Chief R&D Officer gave up 3,907 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 7,038 shares (to pay taxes)
- 4 Open-market sale EVP & Chief Financial Officer sold 42,981 shares at an average $9.53 ($409,680)
Page 8 of 36 · 705 filings